Julia
Winkelblech
ab,
Xiulan
Xie
c and
Shu-Ming
Li
*ab
aPhilipps-Universität Marburg, Institut für Pharmazeutische Biologie und Biotechnologie, Robert-Koch-Straße 4, 35037 Marburg, Germany. E-mail: shuming.li@staff.uni-marburg.de
bZentrum für Synthetische Mikrobiologie, Philipps-Universität Marburg, Hans-Meerwein-Straße, D-35032 Marburg, Germany
cPhilipps-Universität Marburg, Fachbereich Chemie, Hans-Meerwein-Straße, 35032 Marburg, Germany
First published on 20th September 2016
Prenylated secondary metabolites including indole derivatives usually demonstrate improved biological and pharmacological activities, which make them promising candidates for drug discovery and development. The transfer reactions of a prenyl moiety from a prenyl donor, e.g. dimethylallyl diphosphate (DMAPP), to an acceptor is catalysed by prenyltransferases. One special group of such enzymes uses DMAPP and tryptophan as substrates with dimethylallyltryptophans as reaction products and functions therefore as dimethylallyltryptophan synthases (DMATSs). Sequence homology search with known tryptophan prenyltransferases from Streptomyces led to identification of a putative prenyltransferase gene MolI14.36 in Micromonospora olivasterospora. Expression and biochemical investigations revealed that MolI14.36 acts as a tryptophan C6-prenyltransferase (6-DMATSMo). Study on substrate specificity of 6-DMATSMo displayed a significantly high activity towards D-tryptophan, which prompted us to carry out comparative studies on enantioselectivity, regioselectivity and multiple prenylation ability of additional DMATSs including FgaPT2, 5-DMATS, 5-DMATSSc, 6-DMATSSv, 6-DMATSSa and 7-DMATS towards L- and D-isomers of tryptophan and their analogues. The relative activities of the tested enzymes towards D-tryptophan differ clearly from each other. Incubation of L-, D-isomers or the racemates of 5-, 6- and 7-methyltryptophan revealed distinctly different preferences of the DMATS enzymes. Interestingly, 6-DMATSMo and 5-DMATSSc accepted 5-methyl-D-tryptophan much better than the L-enantiomer. Furthermore, the conversion yields of the D-isomers were strongly inhibited in the reactions with racemates. More interestingly, the regioselectivities of FgaPT2, 5-DMATSSc and 7-DMATS towards D-tryptophan and its C5-methylated derivative differed clearly from those of the L-forms. In addition, both mono- and diprenylated products were clearly detected for 5-DMATSSc with L- and D-enantiomers of tryptophan and their methylated derivatives.
One special group of prenyltransferases uses dimethylallyl diphosphate (DMAPP) as the donor and L-tryptophan as the acceptor and functions thus as dimethylallyltryptophan synthase (DMATS). For example, FgaPT2 from the ascomycetous fungus Aspergillus fumigatus (A. fumigatus) catalyses the transfer of a dimethylallyl moiety from DMAPP to C-4 of L-tryptophan and is involved in the biosynthesis of ergot alkaloids.17 Later on, at least six additional fungal DMATSs were identified, which act as C4-, C5-, and C7-prenylating enzymes.11 In contrast with DMATSs from fungi, a few members of the bacterial tryptophan prenyltransferases were only recently characterised biochemically. Therefore, biochemical characterisation of new DMATSs from bacteria will contribute to our understanding on the catalytic features of these enzymes from different origins. The known bacterial DMATSs are from actinomycetes, catalyse the transfer of the dimethylallyl moiety to C-5, C-6 or C-7 of the indole ring, and are involved in the biosynthesis of prenylated indole derivatives.11 For example, IptA from Streptomyces sp. SN-593 functions as a 6-DMATS and is involved in the biosynthesis of 6-dimethylallylindole-3-carbaldehyde.18 Three IptA orthologues, IptAAm from Actinoplanes missouriensis,19 6-DMATSSa from Streptomyces ambofaciens (S. ambofaciens), and 6-DMATSSv from S. violaceusniger have been recently identified and characterised.20SCO7467 from S. coelicolor A3(2) belongs to a gene cluster being responsible for the biosynthesis of 5-dimethylallylindole-3-acetonitrile and the encoded protein acts as a 5-DMATS (5-DMATSSc).21,22 Recently, Wu et al. have identified a biosynthetic gene cluster for a new antibiotic 7-prenylisatin in Streptomyces MBT28-91. Thereby, the prenyltransferase IsaA catalyses the prenylation of L-tryptophan at C-7.23
In the present study, we continue to expand our knowledge on DMATSs from bacteria by cloning, expression and biochemical investigations on a putative prenyltransferase MolI14.36 from Micromonospora olivasterospora (M. olivasterospora). Biochemical investigations revealed that MolI14.36 acts as a tryptophan C6-prenyltransferase (6-DMATSMo). Previous studies on DMATSs revealed that L-tryptophan was much better accepted than D-tryptophan.24 In comparison, D-tryptophan was very well accepted by 6-DMATSMo. This finding promoted us to carry out systematic investigation on the acceptance and enzyme products of L- and D-tryptophan and their methylated derivatives including 5-, 6-, and 7-methyltryptophan by DMATSs from bacteria and fungi. These include three fungal (FgaPT2, 5-DMATS, and 7-DMATS) and four bacterial DMATSs (5-DMATSSc, 6-DMATSSa, 6-DMATSSv, and 6-DMATSMo). Evaluation of the enzyme products demonstrated a clear difference in substrate specificity, regioselectivity of the prenyl transfer reactions as well as the ability for multiple prenylation.
MolI14.36 was then cloned from genomic DNA into the expression vector pHIS8 and overexpressed in E. coli. The recombinant His8-tagged protein with a molecular mass of 43.5 kDa was purified to near homogeneity with a yield of 16 mg per litre culture (Fig. S1, ESI†). Size exclusion chromatography revealed that the enzyme acts as a monomer.
To prove its function and substrate specificity, the purified recombinant MolI14.36 (1 μM) was incubated with 0.5 mM of L-tryptophan (1a), D-tryptophan (1b), and eight analogues thereof (2a, 3a, 4–8, and 9a) in the presence of 1 mM DMAPP. To show the relationships of the enantiomers, we use Arabic numbers for racemates, numbers with a for L-isomers and with b for D-isomers. After incubation at 37 °C for 1 h, the reaction mixtures were analysed on HPLC under the conditions listed in Table S1 in the ESI.† As shown in Table 1 and the ESI (Fig. S2 and S3†), eight of them, 1a, 1b, 2a, 3a, 4, 5, 8, and 9a, were well accepted by this enzyme, with 1a as the best substrate. In the presence of L-tryptophan (1a), MolI14.36 also used geranyl diphosphate as the prenyl donor, but with a significantly lower product yield than with DMAPP (about 10% of that of DMAPP). Farnesyl diphosphate was not accepted by MolI14.36 (Table S2, ESI†). HPLC analysis of the reaction mixtures of MolI14.36 with seven tryptophan-containing cyclic dipeptides showed product formation, but with much lower conversion yields than with tryptophan and its analogues (less than 8% of that of 1a) (Table S3, ESI†). These results provided evidence for the function of MolI14.36 as a dimethylallyl diphosphate:L-tryptophan transferase.
To confirm the prenylation in their structures and particularly the prenylation positions, the enzyme products of tryptophan and its analogues were isolated from large-scale incubation mixtures on preparative HPLC and subsequently analysed by MS and NMR including homonuclear correlation spectroscopy (1H–1H COSY) for 5-C5–5-C7, 6-C6 and 6-C7 (Tables S4–S7 and Fig. S4–S22, ESI†). For better understanding, the enzyme products were termed by addition of the prenylation position like C4, C5, C6 or C7 to the number of the substrate. Inspection of the NMR spectra of the isolated peaks confirmed the unique C6-prenylated products 1a-C6, 1b-C6, 2a-C6, 3a-C6, 4-C6, 8-C6, and 9a-C6 from the reaction mixtures of 1a, 1b, 2a, 3a, 4, 8, and 9a, whereas three products with the prenyl moiety attached to C-5 (5-C5), C-6 (5-C6) and C-7 (5-C7) in a ratio of 0.6:
1
:
0.6 were identified in the reaction mixture of 5. Two products either 6-C6 and 6-C7 or 7-C5 and 7-C6 were detected in those of 6 and 7 (see the ESI† for detailed structure elucidation, Tables S5–S7, Fig. S4–S22†).
In conclusion, MS and NMR analyses of the isolated enzyme products prove that MolI14.36 acts as a L-tryptophan C6-prenyltransferase and is termed 6-DMATSMo, in analogy to the notation of 6-DMATSSa and 6-DMATSSv.20 6-DMATSMo catalyses a unique or predominant C6-prenylation at the indole ring of tryptophan and its analogues (Table 1). If the position 6 is blocked by a methyl group as in the case of 7, a switch of the prenylation site to C-7 was detected, as observed for IptA and 6-DMATSSa, previously.18,20
Additional biochemical characterisation revealed that metal ions are not essential for the enzyme activity as observed for other members of the DMATS superfamily (Fig. S23, ESI†).18,20,25 Furthermore, the function of 6-DMATSMo as a tryptophan prenyltransferase was justified by kinetic studies. The KM value of 0.014 ± 0.002 mM and a turnover number kcat of 0.07 ± 0.002 s−1 were determined for 1a. The kinetic parameters for the prenyl donor DMAPP were found to be 0.037 ± 0.007 mM and 0.08 ± 0.004 s−1, respectively (Fig. S24, ESI†). For comparison of the substrate preferences of 6-DMATSMo and its orthologues 6-DMATSSa and 6-DMATSSv, enzyme assays of 1a, 1b, 2a, 3a, 4–8 and 9a were carried out for the three 6-DMATSs under similar conditions and the relative enzyme activities to 1a were compared with each other (Fig. S3, ESI†). In summary, with the exception for 3a, 6-DMATSSa and 6-DMATSSv seem to share similar substrate preferences towards the tested tryptophan analogues, whereas 6-DMATSMo shows more distinct preferences from those of the two other 6-DMATSs. 1b, 4, 5, and 8 were better accepted by 6-DMATSMo, whereas 6, 7, and 9a were better substrates for the other two 6-DMATS enzymes. The most remarkable feature is the high acceptance of 1b by 6-DMATSMo, with a relative activity of approximately 50% of that of 1a (Table 1 and Fig. S3, ESI†). To the best of our knowledge, such high conversion of 1b has not been reported for other prenyltransferases prior to this study. In comparison, less than 25% relative activities of that of 1a were detected for 6-DMATSSa and 6-DMATSSv with 1b under these conditions. These results prompted us to have detailed insights into the enantioselectivity of the DMATS enzymes towards tryptophan.
For investigations on substrate preferences, the seven DMATSs were incubated with the prenyl donor DMAPP and 1a, 1b, or their racemate 1. The relative activities to 1a were determined by HPLC analysis on the CHIRALPAK® Zwix(+) column. The prenylation of the enzyme products was proven by LC-MS analysis (Table 2 and Fig. 1, S25–S48, ESI†). As given in Table 2, clearly different enantioselectivities were observed for the tested DMATSs. 5-DMATS and 6-DMATSMo accepted 1b much better than other enzymes, with relative activities of 34.7 and 45.7% of those of L-tryptophan (1a), respectively. In contrast, 1b was a very poor substrate for FgaPT2 and 7-DMATS with relative conversion yields of approximately 5 and 6%, respectively, corresponding well to the data reported previously.17,27,28,33 In the reaction mixtures of racemates, the conversion of 1b was strongly reduced, indicating an inhibition. For better understanding of the observed acceptance of 1a and 1b by the tested DMATSs, kinetic parameters were determined by nonlinear regression using GraphPad Prism 4.0 (Fig. S49–S55, ESI†). All investigated reactions apparently followed the Michaelis–Menten kinetics. The calculated KM values of the seven DMATSs for 1a varied from 0.012 mM to 0.055 mM, whereas those for 1b were found in the range of 0.10 to 1.76 mM (Table 3). The significantly higher affinity of the enzymes to the L-form is justified by their native functions as L-tryptophan prenyltransferases and also explained in parts the very low conversion of 1b in the reaction with the racemate. It is plausible that in the initial phase of the reactions with racemates, only 1a was used as substrate by the enzymes. However, the higher affinity and turnover numbers of the tested enzymes towards 1a than 1b could not explain the observed very low conversion of 1b. Under the conditions used for the conversion yields given in Table 2, 1a was almost completely converted. Therefore, we speculated that the products of 1a should also contribute to the inhibition of 1b reactions.
![]() | ||
Fig. 1 Evaluation of the enantioselectivity of (A) 5-DMATS and (B) 6-DMATSMo. The enzymes were incubated with 1 mM DMAPP and 0.5 mM of L-tryptophan, D-tryptophan or a combination of both (1 mM) and the reaction products were profiled by LC-MS and HPLC. 1 μM of the indicated enzyme was incubated with the indicated substrate(s). UV detection was carried out with a diode array detector and illustrated for absorption at 277 nm. Additional chromatograms and MS analyses for all tested enzymes and substrates are provided as Fig. S25–S48 in the ESI.† |
Substrate | Relative conversion yields [%] | |||||||
---|---|---|---|---|---|---|---|---|
FgaPT2 | 5-DMATS | 5-DMATSSc | 6-DMATSSa | 6-DMATSSv | 6-DMATSMo | 7-DMATS | ||
The enzyme assays contained 0.5 mM of the L- or D-isomers or 1 mM of the racemates and 1 mM DMAPP were incubated at 37 °C for 1.5 h with 1 μM purified protein. The conversion yields of L-tryptophan (1a) with FgaPT2 at 97.3%, 5-DMATS at 98.4%, 5-DMATSSc at 96%, 6-DMATSMo at 82.7%, 6-DMATSSv at 96.1%, 6-DMATSSa at 97.0%, and with 7-DMATS at 88.9% were defined as 100% relative activity, respectively. The conversion yields of D- or L-enantiomers in the reaction mixtures with racemates were calculated separately by considering the respective enantiomer as the substrate.a Diprenylated products, with a ratio of 0.6![]() ![]() ![]() ![]() |
||||||||
L-Tryptophan | 1a | 100.0 ± 2.5 | 100.0 ± 0.7 | 100.0 ± 0.04a | 100.0 ± 2.7 | 100.0 ± 0.9 | 100.0 ± 12.2 | 100.0 ± 4.3 |
D-Tryptophan | 1b | 5.2 ± 0.9 | 34.7 ± 4.4 | 20.2 ± 2.6b | 10.4 ± 0.02 | 16.8 ± 1.1 | 45.7 ± 2.9 | 6.4 ± 0.2 |
DL-Tryptophan | 1a | 96.3 ± 2.1 | 96.7 ± 4.8 | 103.5 ± 4.7 | 99.4 ± 8.2 | 87.1 ± 2.6 | 99.9 ± 1.0 | 98.9 ± 1.5 |
1b | ≤0.5 | 12.6 ± 2.2 | ≤0.5 | 1.6 ± 0.3 | 2.5 ± 0.01 | 1.3 ± 0.1 | ≤0.5 | |
5-Methyl-L-tryptophan | 6a | 43.0 ± 1.8 | 2.5 ± 0.1 | 2.3 ± 0.2 | 102.5 ± 0.2 | 100.5 ± 0.7 | 12.9 ± 0.2 | 84.9 ± 3.8 |
5-Methyl-D-tryptophan | 6b | ≤0.5 | ≤0.5 | 57.3 ± 1.8 | 11.4 ± 0.6 | 22.4 ± 0.4 | 66.6 ± 0.5 | 2.5 ± 0.6 |
5-Methyl-DL-tryptophan | 6a | 22.4 ± 4.0 | 3.1 ± 1.1 | 3.8 ± 0.6 | 76.2 ± 6.5 | 100.7 ± 4.1 | 13.0 ± 0.6 | 97.9 ± 4.3 |
6b | ≤0.5 | ≤0.5 | ≤0.5 | 2.4 ± 1.1 | 4.7 ± 0.1 | ≤0.5 | ≤0.5 | |
6-Methyl-L-tryptophan | 7a | 84.0 ± 1.2 | 85.5 ± 5.7 | 15.0 ± 1.7 | 9.1 ± 1.7 | 35.4 ± 2.3 | 5.5 ± 0.2 | 17.5 ± 1.1 |
6-Methyl-D-tryptophan | 7b | ≤0.5 | ≤0.5 | 1.1 ± 0.1 | ≤0.5 | ≤0.5 | 1.2 ± 0.2 | ≤0.5 |
6-Methyl-DL-tryptophan | 7a | 61.2 ± 0.8 | 82.5 ± 5.1 | 15.1 ± 0.2 | 8.2 ± 0.4 | 33.2 ± 0.6 | 5.0 ± 0.6 | 16.6 ± 0.9 |
7b | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | |
7-Methyl-L-tryptophan | 8a | 97.8 ± 1.7 | 75.7 ± 0.5 | 8.2 ± 2.3 | 4.3 ± 0.2 | 7.4 ± 1.6 | 72.4 ± 8.5 | ≤0.5 |
7-Methyl-D-tryptophan | 8b | ≤0.5 | 3.7 ± 1.4 | 1.9 ± 0.2 | ≤0.5 | ≤0.5 | 13.8 ± 3.8 | ≤0.5 |
7-Methyl-DL-tryptophan | 8a | 68.2 ± 5.0 | 70.6 ± 4.2 | 5.9 ± 0.2 | 3.8 ± 0.4 | 7.5 ± 0.7 | 72.5 ± 13.1 | ≤0.5 |
8b | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 | ≤0.5 |
DMATS | L-Tryptophan | D-Tryptophan | 5-Methyl-L-tryptophan | 5-Methyl-D-tryptophan | ||||
---|---|---|---|---|---|---|---|---|
1a | 1b | 6a | 6b | |||||
K M [mM] | k cat [s−1] | K M [mM] | k cat [s−1] | K M [mM] | k cat [s−1] | K M [mM] | k cat [s−1] | |
—, Not determined. | ||||||||
FgaPT2 | 0.034 ± 0.003 | 0.67 ± 0.01 | 0.10 ± 0.007 | 0.012 ± 0.0002 | — | — | — | — |
5-DMATS | 0.055 ± 0.002 | 0.39 ± 0.001 | 0.62 ± 0.08 | 0.066 ± 0.004 | — | — | — | — |
5-DMATSSc | 0.020 ± 0.002 | 0.19 ± 0.004 | 1.47 ± 0.08 | 0.046 ± 0.001 | 0.009 ± 0.001 | 0.005 ± 0.0001 | 0.03 ± 0.01 | 0.035 ± 0.005 |
6-DMATSSa | 0.012 ± 0.001 | 0.10 ± 0.002 | 1.02 ± 0.07 | 0.021 ± 0.001 | — | — | — | — |
6-DMATSSv | 0.022 ± 0.002 | 0.19 ± 0.004 | 0.77 ± 0.08 | 0.021 ± 0.001 | — | — | — | — |
6-DMATSMo | 0.014 ± 0.002 | 0.07 ± 0.002 | 0.47 ± 0.04 | 0.066 ± 0.002 | 0.008 ± 0.001 | 0.012 ± 0.0002 | 0.30 ± 0.05 | 0.042 ± 0.003 |
7-DMATS | 0.043 ± 0.004 | 0.12 ± 0.002 | 1.76 ± 0.19 | 0.013 ± 0.001 | — | — | — | — |
The calculated turnover numbers (kcat) for 1a from 0.07 to 0.67 s−1 are in almost all cases much higher than those for 1b between 0.012 and 0.066 s−1. In comparison to 1b reactions with other enzymes, relative high affinity and turnover numbers were determined for those with 5-DMATS and 6-DMATSMo. The turnover numbers of 6-DMATSMo towards 1a and 1b are nearly identical at approximately 0.07 s−1. These data supported the high conversion yields of 1b by 5-DMATS and 6-DMATSMo given in Table 2.
![]() | ||
Fig. 2 HPLC identification of the enzyme products of DMATSs and 1a or 1b. The enzymes were incubated with 1 mM DMAPP and 1 mM of L-tryptophan (1a) or D-tryptophan (1b). Detailed conditions of the enzyme assays are given in Table S9 in the ESI.† For HPLC analysis, an Eclipse XDB-C18 column was used (condition 4 in Table S1†). Detection was carried out on a diode array detector and illustrated for absorption at 277 nm. |
Substrate structures | Enzyme products and their ratios | |||||||
---|---|---|---|---|---|---|---|---|
FgaPT2 | 5-DMATS | 5-DMATSSc | 6-DMATSSa | 6-DMATSSv | 6-DMATSMo | 7-DMATS | ||
The ratio of the enzyme products was evaluated from HPLC chromatograms.a The ratio of the enzyme products was evaluated from 1H NMR spectra.b Product formation was detected by LC-MS analysis. | ||||||||
1a |
![]() |
C4 | C5 | C5 | C6 | C6 | C6 | C7 |
1b |
![]() |
C4![]() ![]() ![]() ![]() |
C5 |
C5![]() ![]() ![]() ![]() |
C6 | C6 | C6 |
C6![]() ![]() |
0.2![]() ![]() ![]() ![]() |
0.4![]() ![]() ![]() ![]() |
0.05![]() ![]() |
||||||
6a |
![]() |
C4 |
C6![]() ![]() |
C6 | C6 |
C6![]() ![]() |
C7 | |
1![]() ![]() |
1![]() ![]() |
|||||||
6b |
![]() |
C4![]() ![]() |
C6![]() ![]() |
C6 | C6 |
C6![]() ![]() |
C6![]() ![]() |
|
1![]() ![]() |
1![]() ![]() |
1![]() ![]() |
1![]() ![]() |
To prove the prenylation positions, the seven DMATSs were incubated with 1a and 1b and analysed on an achiral XDB-C18 column under the improved HPLC condition 4 (Fig. 2 and Tables S1, S9, ESI†). Under this condition, the enantiomeric pairs 1a and 1b have the same retention times, which is also true for their derivatives with the same prenylation positions. More importantly, C4-, C5-, C6-, and C7-prenylated tryptophan were well separated from each other. The results in Fig. 2 confirmed the previously published regiospecific prenylation of 1a by the tested DMATSs. The enzyme products of 1b with 5-DMATS and the three C6-prenyltransferases 6-DMATSSa, 6-DMATSSv and 6-DMATSMo had the same prenylation positions as those of 1a. Interestingly, the main product of 1b with FgaPT2 was prenylated at position C-5 instead of C-4. C4- and likely C7-prenylated derivatives were detected as minor products (Table 4 and Fig. 2). As aforementioned, three products 1b-C5, 1b-C6, and 1b-C7 with a ratio of 0.4:
1.0
:
0.4 were detected in the reaction mixture of 1b with 5-DMATSSc (Fig. 2, Tables 4, S8 and Fig. S56, ESI†).20,25,37 HPLC analysis of the reaction mixture of 1b with 7-DMATS proved the main product to be 7-DMA-D-tryptophan (1b-C7) and the minor product the C6-prenylated derivative 1b-C6 in a ratio of 1
:
0.05 (Fig. 2 and Table 4). The observed changes in regioselectivity could indicate different orientations of the two enantiomers in the active sites. Crystal structures of such bacterial tryptophan prenyltransferases could provide detailed insights into their reaction chambers.
![]() | ||
Fig. 3 HPLC analysis of the reaction mixtures of 5-DMATSSc with L- and D-enantiomers of tryptophan and methylated derivatives. 1 μM of the enzyme was incubated with 1 mM DMAPP and 0.5 mM of the indicated substrate(s) at 37 °C for 16 h. The reaction mixtures were analysed on an Eclipse Plus-C18 column (condition 6, Table S1, ESI†). The structures of the enzyme products of 1a, 1b, and 6b have been elucidated by NMR and MS analyses. The main products of 7a, 7b, 8a, and 8b are expected to be C5-prenylated derivatives. Detection was carried out with a diode array detector and illustrated for absorption at 277 nm. |
Structure elucidation of the isolated diprenylated peak by NMR analysis confirmed the C5,C6-diprenylation in the main product 1b-C5,C6 (Table S8 and Fig. S58, ESI†) with three singlets at 7.45, 7.15 and 7.10 ppm for H-4, H-7 and H-2, respectively. In this spectrum, signals of aromatic protons for C5,C7-diprenylated derivatives 1b-C5,C7 were also detected, with a low intensity of 5% of that of 1b-C5,C6. To the best of our knowledge, this is the first report on diprenylation of tryptophan by a tryptophan prenyltransferase. By UV detection mentioned above, diprenylated products of 1a, 1b and 1 were only observed for 5-DMATSSc after incubation for 1.5 h. By using the extracted ion chromatogram (EIC) mode, diprenylated products were also detected for almost all the DMATSs with 1a, with an exception for FgaPT2 (Fig. S25–S48, ESI†). However, the product yields were less than 0.5% of those of monoprenylated derivatives.
It seems that FgaPT2 had a much higher enantioselectivity than other tested enzymes and accepted no D-enantiomers 6b, 7b, or 8b. 7b and 8b were no substrates for 6-DMATSSa, 6-DMATSSv, and 7-DMATS. No product formation was detected in the reaction mixture of 7b with 5-DMATS. From Table 2, it is obvious that the reactions of L-enantiomers were almost not inhibited by D-enantiomers and nearly the same activities were detected for the L-enantiomers in the racemates. Interestingly, 6b was a much better substrate for 5-DMATSSc and 6-DMATSMo than 6a. Relative conversion yields of 57.3 ± 1.8 and 66.6 ± 0.5% of that of 1a were calculated for the reactions of 6b with 5-DMATSSc and 6-DMATSMo, respectively, whereas the values for 6a are 2.3 ± 0.2 and 12.9 ± 0.2%, respectively (Table 2 and Fig. 4).
More interestingly, 6b in the racemate 6 was not converted by these two enzymes, while similar conversion yields for 6a were observed. This indicated an inhibition of the 6b reactions in the presence of 6a, which could be explained by determination of their kinetic parameters. Kinetic parameters of 6-DMATSMo and 5-DMATSSc were then determined for 6a and 6b (Table 3 and Fig. S61–S62, ESI†). Substrate inhibition was observed for the 5-DMATSSc reaction with 6b at concentrations higher than 0.05 mM. Therefore, the KM value was determined from graphical nonlinear evaluation for concentrations less than 0.05 mM. For calculation of kcat, the maximal velocity vmax at 0.05 mM 6b was used (Fig. S61, ESI†). For other reactions, kinetic parameters were calculated from nonlinear regression (Fig. S61 and S62, ESI†) and are given in Table 3. KM values of 0.009 ± 0.001 and 0.03 ± 0.01 mM and kcat values of 0.005 ± 0.0001 and 0.035 ± 0.005 s−1 were calculated for 5-DMATSSc reactions with L- and D-isomers, respectively. For the 6-DMATSMo reaction with 6a, a KM value of 0.008 ± 0.001 mM and a kcat of 0.012 ± 0.0002 s−1 were determined. In comparison, a significantly higher KM value of 0.30 ± 0.05 mM and larger kcat of 0.042 ± 0.003 s−1 were calculated for the 6-DMATSMo reaction with 6b. In summary, 5-DMATSSc and 6-DMATSMo also display higher affinities to the L- than the D-enantiomer. The turnover numbers for the D-enantiomer are, however, clearly higher than those of the L-enantiomer, confirming the observed conversion yields of the reactions with pure enantiomers and the inhibition of the 6b reactions in the presence of 6a in the racemates. Due to the high affinity of the DMATSs towards the L-form, the active site of the enzyme will be occupied by the L-enantiomer, so that no or very low prenylation of 6b is observed in the reaction with the racemate.
In contrast with the highly regiospecific prenylation on the L-tryptophan of the tested enzymes, the L-tryptophan C4-prenyltransferase FgaPT2 and C5-prenyltransferase 5-DMATSSc displayed a reduced regioselectivity towards D-tryptophan with C5- and C6-prenylated derivatives as the main products, respectively. Clearly different regioselectivities were also identified for the enantiomers of 5-methyltryptophan with FgaPT2, 5-DMATSSc and 7-DMATS. Furthermore, diprenylation of tryptophan by 5-DMATSSc was the first example that a tryptophan prenyltransferase catalyses two successive prenylation steps. These results expand our knowledge on the similarity and differences in the biochemical features of the tryptophan prenyltransferases. Moreover, the presented biochemical properties of these enzymes make them potential biocatalysts in chemical synthesis for prenylated indole derivatives, which represent promising candidates for drug discovery and development in the pharmaceutical industry. As mentioned in the Introduction, D-amino acids and their derivatives are interesting drug candidates and could be used for treatment of different diseases.3,39–44 Testing the bioactivity of these compounds is intended in the near future.
With the isolated genomic DNA as the template, a PCR fragment of 1143 bp containing the coding sequence of MolI14.36 was amplified by using the Expand high fidelity kit (Roche Diagnostic, Mannheim, Germany) and the primers Mol_SacI_fw: (5′-ATGGCCGGCTTGTCCG-3′) and Mol_HindIII_Rev: 5′-
TCAGGGTCGGGTACGGC-3′). Bold underlined letters represent the restriction sites for SacI and HindIII, located immediately before the predicted start and at the stop codon in the primer sequences. PCR amplification was performed on an iCycler from Bio-Rad. The PCR product was cloned via the pGEM-T Easy vector into pHIS8
48 resulting in the expression construct pJW32. E. coli BL21 [DE3] cells harbouring pJW32 were cultivated in 1 L liquid lysogeny broth (LB) medium supplemented with kanamycin (50 μg ml−1) until an OD600 of 0.6. For induction of gene expression, IPTG was added to a final concentration of 1 mM. After further incubation at 30 °C and 220 rpm for 16 h, the recombinant His8-tagged protein was purified on Ni-NTA agarose according to the manufacturer's protocol.
Kinetic parameters of 6-DMATSMo toward DMAPP were determined with 1 mM of 1a as the prenyl acceptor. Assays containing 229.9 nM 6-DMATSMo and DMAPP at final concentrations of 0.002 to 0.5 mM were incubated for 30 min. For determination of the kinetic parameters of different DMATSs towards 1a, DMAPP at 1 mM and 1a at final concentrations of up to 1 mM were used. Assays with 36.2 nM FgaPT2, 99.2 nM 5-DMATS, 118.5 nM 5-DMATSSc, 121.7 nM 6-DMATSSa, 231.0 nM 6-DMATSSv, 229.9 nM 6-DMATSMo, and 228.8 nM 7-DMATS were incubated for 15 min or in the case of 6-DMATSMo for 30 min. For determination of the kinetic parameters of 1b, the maximal substrate concentration was increased to 2 mM or even 4 mM in the case of 5-DMATSSc. The assays contained 905.8 nM FgaPT2, 396.8 nM 5-DMATS, 473.9 nM 5-DMATSSc, 486.6 nM 6-DMATSSa, 461.9 nM 6-DMATSSv, 459.8 nM 6-DMATSMo, or 1.4 μM 7-DMATS and were incubated for 30 min, or in the case of 5-DMATSSc for 15 min. The assays for determination of the kinetic parameters of 6-DMATSMo for 6a and 6b contained 1 mM DMAPP, 459.8 nM of the recombinant protein, 6a from 0.002 to 0.5 mM or 6b from 0.01 to 1 mM. The reaction mixtures were incubated for 30 min. For the 5-DMATSSc reactions with 6a and 6b, the assays contained 7.1 μM and 473.9 nM of the recombinant protein and 0.002 to 0.5 mM of 6a or 6b, which were incubated for 15 min. The conditions for all other enzyme assays are given in the legends of respective figures or tables.
Assays for isolation of the enzyme products of 6-DMATSMo were prepared in large scales (10 ml) containing 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 1 mM L-tryptophan or its analogues, 2 mM DMAPP, and recombinant protein in an adequate quantity (2.3–6.9 μM). Enzyme products of 6-DMATSMo with 5-methyl-D-tryptophan as well as 5-DMATSSc with D-tryptophan and 5-methyl-D-tryptophan were isolated from up-scaled assays (5 ml) containing 50 mM Tris-HCl (pH 7.5), 5 mM MgCl2, 1 mM D-tryptophan or 0.5 mM 5-methyl-D-tryptophan, 2 mM DMAPP and the recombinant protein in an adequate quantity (4.7–11.9 μM 5-DMATSSc or 4.6–11.5 μM 6-DMATSMo). Assays were incubated for 16 h.
All enzyme reactions were terminated by addition of one volume of methanol. Assays of up to 100 μl were centrifuged at 17000g for 20 min before further analysis on HPLC. Isolation assays of 5–10 ml were centrifuged at 4500g for 30 min and the obtained supernatants were concentrated on a rotating vacuum evaporator at 35 °C to a volume of 1 ml for isolation on HPLC.
To detect prenylation, the assays were analysed on an Agilent HPLC 1260 equipped with a Bruker microTOF QIII mass spectrometer. The applied method is illustrated as condition 3. Chromatograms with UV detection and the extracted ion chromatograms (EIC) are given in Fig. 1 and 4 as well as in Fig. S25–S48 (ESI†).
Reaction mixtures for better separation of the enzyme products with prenylations at different positions were analysed under condition 4 for L- and D-tryptophan or under condition 5 for the L- and D-forms of 5-, 6-, and 7-methyltryptophan as substrates. Enzyme assays with 5-DMATSSc, illustrated in Fig. 3, were measured under condition 6. The enantiomeric substrates were separated isocratically with the same chiral column by using methanol as the elution solvent (condition 7).
For isolation of the prenylated products, the same HPLC equipment under condition 8 or 9 was used. Detection was carried out with a photodiode array detector and illustrated at 277 nm in this paper.
Footnote |
† Electronic supplementary information (ESI) available. See DOI: 10.1039/c6ob01803c |
This journal is © The Royal Society of Chemistry 2016 |